Cathrine Cotman
Known title: DirectorCIK: 0001927679
Cathrine Cotman's purchase track record
How the stock did after each of Cathrine Cotman's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since March 10, 2023
Stock higher 6 months later
50%
3 months: 50%
Median 6-month return
+3.9%
3 months: +3.5%
Beat the S&P 500
50%
median -9.7% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/4/2025 | CHCT | $59K | +23.4% | +27.7% | +7.2% |
| 4/30/2025 | CHCT | $51K | -5.1% | -10.3% | +23.7% |
| 8/13/2024 | CHCT | $35K | +7.1% | +13.2% | +11.7% |
| 3/10/2023 | CHCT | $10K | -0.2% | -5.4% | +15.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CHCT | ▲ Buy | Grant | 6,036 | $104K | 5/21/2026 | View on chart |
| CHCT | ▲ Buy | Grant | 6,222 | $0 | 5/7/2026 | View on chart |
| CHCT | ▲ Buy | Open Market | 4,000 | $59K | 11/4/2025 | View on chart |
| CHCT | ▲ Buy | Grant | 6,250 | $104K | 5/15/2025 | View on chart |
| CHCT | ▲ Buy | Grant | 6,524 | $0 | 5/1/2025 | View on chart |
| CHCT | ▲ Buy | Open Market | 3,000 | $51K | 4/30/2025 | View on chart |
| CHCT | ▼ Sell | Open Market | 3,000 | $51K | 4/30/2025 | View on chart |
| CHCT | ▲ Buy | Open Market | 2,000 | $35K | 8/13/2024 | View on chart |
| CHCT | ▲ Buy | Grant | 4,285 | $104K | 5/16/2024 | View on chart |
| CHCT | ▲ Buy | Grant | 4,414 | $0 | 5/2/2024 | View on chart |
| CHCT | ▲ Buy | Grant | 2,256 | $80K | 5/19/2023 | View on chart |
| CHCT | ▲ Buy | Grant | 2,751 | $0 | 5/4/2023 | View on chart |
| CHCT | ▲ Buy | Open Market | 277 | $10K | 3/10/2023 | View on chart |
| CHCT | ▲ Buy | Grant | 2,185 | $80K | 5/20/2022 | View on chart |
| CHCT | ▲ Buy | Grant | 2,693 | $0 | 5/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Evercore ISI Lowers CHCT Price Target to $17
Evercore ISI Group has maintained its In-Line rating on Community Healthcare Trust but lowered its price target to $17. This move places the firm's estimate at the lower end of the current analyst range, which spans from $17.00 to $18.00. The adjustment reflects a modestly more conservative outlook for the company's near-term performance relative to previous expectations.
Evercore ISI Lowers CHCT Price Target to $17. Evercore ISI Group has maintained its In-Line rating on Community Healthcare Trust but lowered its price target to $17. This move places the firm's estimate at the lower end of the current analyst range, which spans from $17.00 to $18.00. The adjustment reflects a modestly more conservative outlook for the company's near-term performance relative to previous expectations.